A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research

Psychoneuroendocrinology

Volumn 36, Issue 8, 2011, Pages 1114-1126

  MacDonald, Elayne ^a   Dadds, Mark R ^a   Brennan, John L ^b   Williams, Katrina ^c   Levy, Florence ^b   Cauchi, Avril J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Drug awareness; Intranasal; Oxytocin; Safety; Side effects; Social behaviour

Indexed keywords

OXYTOCIN; PLACEBO;

ABDOMINAL PAIN; AMNESIA; ANXIETY; AUTISM; CONSTIPATION; DELUSION; DIZZINESS; DROWSINESS; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DRY THROAT; EUPHORIA; FLUID INTAKE; HALLUCINATION; HUMAN; MEDICAL ASSESSMENT; MENSTRUATION DISORDER; MONITORING; NOSE IRRITATION; OBSESSIVE COMPULSIVE DISORDER; PLASMA OSMOLALITY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHINORRHEA; SELF REPORT; SIDE EFFECT; SOCIAL PHOBIA; SODIUM BLOOD LEVEL; SOMNOLENCE; STOMACH PAIN; SYSTEMATIC REVIEW; TRICHOTILLOMANIA; VERTIGO; XEROSTOMIA;

ADMINISTRATION, INTRANASAL; DRUG TOXICITY; FEMALE; HUMAN EXPERIMENTATION; HUMANS; MALE; MENTAL PROCESSES; OXYTOCIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH;

EID: 80051469915     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.02.015     Document Type: Review

References (74)

1. Alvares G.A., Hickie I.B., Guastella A.J. Acute effects of intranasal oxytocin on subjective and behavioural responses to social rejection. Exp. Clin. Psychopharmacol. 2010, 18:316-321.
2. Andari E., Duhamel J.-R., Zalla T., Herbrecht E., Leboyer M., Sirigu A. Promoting social behaviour with oxytocin in high-functioning autism spectrum disorders. PNAS 2010, 107:4389-4394.
3. Ansseau M., Legrus J.J., Mormont C., Cerfontaine J.L., Papart P., Geenen V., Adam F., Franck G. Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology 1987, 12:231-236.
4. Australian Government Department of Health and Aging Therapeutic Goods Association, 2011. Australian adverse drug reactions bulletin. Available from: (accessed 23.02.11). http://www.tga.gov.au/adr/aadrb.htm.
5. Baumgartner T., Heinrichs M., Vonlanthen A., Fischbacher U., Fehr E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 2008, 58:639-650.
6. Bender L. A Visual Motor Gestalt Test and Its Clinical Use 1938, American Orthopsychiatric Association, New York.
7. Benton A.L. The Revised Visual Retention Test: Clinical and Experimental Applications 1976, Psychological Corporation, New York. 4th ed.
8. Born J., Lange T., Kern W., McGregor G.P., Bickel U., Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nature 2002, 5:514-516.
9. Buchheim A., Heinrichs M., George C., Pokorny D., Koops E., Henningsen P., O'Connor M.-F., Gundel H. Oxytocin enhances the experience of attachment security. Psychoneuroendocrinology 2009, 34:1417-1422.
10. Burri A., Heinrichs M., Schedlowski M., Kruger T.H.C. The acute effects of intranasal oxytocin administration on endocrine and sexual function in males. Psychoneurocrinology 2008, 33:591-600.
11. Bruins J., Hijman R., Van Ree J.M. Effect of a single dose of des-glycinamide vasopressin or oxytocin on cognitive processes in young healthy subjects. Peptides 1992, 13:461-468.
12. Brunton L.L., Lazo J.S., Parker K.L. Goldman & Gilmas: The Pharmacological Basis of Therapeutics 2006, McGraw-Hill Companies, United States, pp. 1507-1509. 11th ed.
13. CBG Medicines Evaluation Board, 2011. Samenvatting van de producthenmerken. Available from: (accessed 23.02.11). http://db.cbg-mel.nl/IB-teksten/h03716.pdf.
14. Cross B.A. The hypothalamus and the mechanism of sympathetico-adrenal inhibition of milk ejection. J. Endocrinol. 1955, 12:15-18.
15. Di Simplicio M., Massey-Chase R., Cowen P.J., Harmer C.J. Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J. Psychopharmocol. 2009, 23:241-248.
16. Ditzen B., Schaer M., Gabriel B., Bodenmann G., Ehlert U., Heinrichs M. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol. Psychiatry 2009, 65:728-731.
17. Domes G., Lischke A., Berger C., Grossmann A., Hauenstein K., Heinrichs M., Herpertz S.C. Effects of intranasal oxytocin on emotional face processing in women. Psychoneurodocrinology 2010, 35:83-93.
18. Domes G., Heinrichs M., Glascher J., Buchel C., Braus D.F., Herpertz S.C. Oxytocin attenuates amygdale responses to emotional faces regardless of valence. Biol. Psychiatry 2007, 62:1187-1190.
19. Domes G., Heinrichs M., Michel A., Berger C., Herpertz S.C. Oxytocin improves mind reading in humans. Biol. Psychiatry 2007, 61:731-733.
20. Du Vigneaud V., Ressler C., Trippett S. The sequence of amino acids in oxytocin with a proposal for the structure of oxytocin. J. Biol. Chem. 1953, 205:949-957.
21. Du Vigneaud V., Ressler C., Swan J.M., Roberts C.W., Katsoyannis P.G., Gordan S. The synthesis of an octapeptide amide with the hormonal activity of oxytocin. J. Am. Chem. Soc. 1953, 75:4879-4880.
22. Epperson C.N., McDougle C.J., Price L.H. Intranasal oxytocin in obsessive-complusive disorder. Biol. Psychiatry 1996, 40:547-549.
23. Epperson C.N., McDougle C.J., Price L.H. Intranasal oxytocin in Trichotillomania. Biol. Psychiatry 1996, 40:559-561.
24. European Medicines Agency, 2011. National competent authorities (human). Available from: (accessed 23.02.11). http://www.ema.europa.eu/ema/index.jsp%3F.
25. Ernst E., Pittler M.H. Assessment of therapeutic safety in systematic reviews: literature review. BMJ 2001, 323:546-547.
26. FDA U.S. food and drug administration, 2011. Medwatch: the FDA safety information and adverse event reporting program. Available from: (accessed 23.02.11). http://www.fda.gov/safety/medwatch/default.htm.
27. Fehm-Wolfsdorf G., Born J. Behavioral effects of neurohypophyseal peptides in healthy volunteers: 10years of research. Peptides 1991, 12:1399-1406.
28. Fewtrell M.S., Loh K.L., Blake A., Ridout D.A., Hawdon J. Randomised double blind trial of oxytocin nasal spray in mothers expressing breast milk for preterm infants. Arch. Dis. Child Fetal Neonatal. Ed. 2006, 91:169-174.
29. Fischer-Shofty M., Shamay-Tsoory S.G., Harari H., Levkovitz Y. The effect of intranasal administration of oxytocin on fear recognition. Neuropsychologia 2010, 48:179-184.
30. Gamer M., Zurowski B., Buchel C. Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9400-9405.
31. Gimpl G. Oxytocin receptor ligands: a survey of the patent literature. Exp. Opin. 2008, 18:1239-1251.
32. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
33. Guastella A.J., Carson D.S., Dadds M.R., Mitchell P.B., Cox R.E. Does oxytocin influence the early detection of angry and happy faces?. Psychoneuroendocrinology 2009, 34:220-225.
34. Guastella A.J., Einfeld S.L., Gray K.M., Rinehart N.J., Tonge B.J., Lambert T.J., Hickie I.B. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol. Psychiatry 2010, 67:692-694.
35. Guastella A.J., Howard A.L., Dadds M.R., Mtchell P., Carson D.S. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneurocrinology 2009, 34:917-923.
36. Guastella A.J., Mitchell P.B., Dadds M.R. Oxytocin increases gaze to the eye region of human faces. Biol. Psychiatry 2008, 63:3-5.
37. Guastella A.J., Mitchell P.B., Mathews F. Oxytocin enhances the encoding of positive social memories in humans. Biol. Psychiatry 2008, 64:256-258.
38. Hanson L.R., Frey W.H. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 2008, 9:S5.
39. Heinrichs M., Baumgartner T., Kirschbaum C., Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 2003, 54:1389-1398.
40. Heinrichs M., Meinlschmidt G., Wippich W., Ehlert U., Hellhammer D.H. Selective amnesic effects of oxytocin on human memory. Physiol. Behav. 2004, 83:31-38.
41. Hollander E., Novotny S., Hanratty M., Yaffe R., DeCaria C.M., Aronowitz B.R., Mosovich S. Oxytocin infusion reduces repetitive behaviours in adults with autistic and Asperger's disorders. Neuropsychopharmacology 2003, 28:193-198.
42. Hollander E., Bartz J., Chaplin W., Phillips A., Sumner J., Soorya L., Anagnostou E., Wassermann S. Oxytocin increases retention of social cognition in autism. Biol. Psychiatry 2007, 61:498-503.
43. Holmes C.L., Landry D.W., Granton J.T. Science review: vasopressin and the cardiovascular system part 1 - receptor physiology. Crit. Care 2003, 7:427-434.
44. Holmes C.L., Landry D.W., Granton J.T. Science review: vasopressin and the cardiovascular system part 2 - clinical physiology. Crit. Care 2004, 8:15-23.
45. Hubner-Mayer B. Pseudotumour cerebri from intranasal oxytocin and excessive fluid intake. Lancet 1996, 347:623.
46. Huntingford P.J. Intranasal use of synthetic oxytocin in management of breast feeding. BMJ 1961, 1:709-711.
47. Keri S., Benedek G. Oxytocin enhances the perception of biological motion in humans. Cogn. Affect. Behav. Neurosci. 2009, 9:237-241.
48. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., Gruppe H., Mattay V.S., Gallhofer B., Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 2005, 25:11489-11493.
49. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., Fehr E. Oxytocin increases trust in humans. Nature 2005, 435:673-676.
50. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroend. 2004, 25:150-176.
51. Lee J.-H., Macbeth A.H., Pagani J.H., Young S.W. Oxytocin: the great facilitator in life. Prog. Neurobiol. 2009, 88:127-151.
52. Legros J.-J. Inhibitory effect of oxytocin on corticotrope function in humans: are vasopressin and oxytocin ying-yang neurohormones?. Psychoneuroendocrinology 2001, 26:649-655.
53. Loke Y.K., Derry S. Reporting of adverse drug reactions in randomized controlled trials - a systematic survey. BMC Clin. Pharmacol. 2001, 1:3.
54. Loke Y.K., Price D., Herxheimer A. Systematic reviews of adverse effects: a framework for a structured approach. BMC Med. Res. Methodol. 2007, 7:32.
55. MacDonald K., MacDonald T.M. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv. Rev. Psychiatry 2010, 18:1-21.
56. Meinlschmidt G., Heim C. Sensitivity to intranasal oxytocin in adult men with early parental separation. Biol. Psychiatry 2007, 61:1109-1111.
57. Newton M., Egli G.E. Effect of intranasal oxytocin on let-down of milk. Am. J. Obstet. Gynecol. 1958, 76:103-107.
58. Novartis Pharmaceuticals, 2011. Novartis Australia health care professionals. Available from: (accessed February 23.02.11). http://www.novartis.com.au/products_healthcare.html.
59. Ohlsson B., Truedsson M., Bengtsson M., Torstenson R., Sjolund K., Bjornsson E.S., Simren M. Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Neurogatroemterol. Motil. 2005, 17:697-704.
60. Petersson M. Cardiovascular effects of oxytocin. Prog. Brain Res. 2002, 139:281-288.
61. Petrovic P., Kalisch R., Singer T., Dolan R.J. Oxytocin attenuates affective evaluations of conditioned faces and amygdale activity. J. Neurosci. 2008, 28:6607-6615.
62. Pitman R.K., Orr S.P., Lasko N.B. Effects of intranasal vasopressin and oxytocin on physiologic responding during personal combat imagery in Vietnam veterans with post-traumatic stress disorders. Psychiatry Res. 1993, 48:107-117.
63. Potter R.R. Water retention due to oxytocin. Obstet. Gynecol. 1964, 23:699-702.
64. Rasmussen M.S., Simonsen J.A., Sandgaard N.C.F., Hoilund-Carlsen P.F., Bie P. Effects of oxytocin in normal man during low and high sodium diets. Acta Physiol. Scand. 2004, 181:247-257.
65. Rimmele U., Hediger K., Heinrichs M., Klaver P. Oxytocin makes a face in memory familiar. J. Neurosci. 2009, 29:38-42.
66. Savaskan E.S., Ehrhardt R., Schulz A., Walter M., Schachinger H. Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology 2008, 33:368-374.
67. Seifer D.B., Sandberg E.C., Ueland K., Sladen R.W. Water intoxication and hyponatremic encephalopathy from the use of an oxytocin nasal spray. A case report. J. Reprod. Med. 1985, 30:225-228.
68. Shamay-Tsoory S.G., Fischer M., Dvash J., Harari H., Perach-Bloom N., Levkovitz Y. Intranasal administration of oxytocin increases envy and schadenfreude (Gloating). Biol. Psychiatry 2009, 66:864-870.
69. Singer T., Snozzi R., Bird G., Petrovic P., Silani G., Heinrichs M., Dolan R.J. Effects of oxytocin and prosocial behaviour on brain responses to direct and vicariously experienced pain. Emotion 2008, 8:781-791.
70. Steyer R., Schwenkmezger P., Notz P., Eid M. Der Mehrdimensionale befindlichkeitsfragebogen MDBF 1997, Hogrefe, Göttingen, Germany.
71. Theodoridou A., Rowe A.C., Penton-Voak I.S., Rogers P.J. Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness. Horm. Behav. 2009, 56:128-132.
72. Unkelbach C., Guastella A.J., Forgas J.P. Oxytocin selectively facilitates recognition of positive sex and relationship words. Psychol. Sci. 2008, 19:1092-1094.
73. Watson D., Clark L.A., Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 1988, 54:1063-1070.
74. Zak P.J., Stanton A.A., Ahmadi S. Oxytocin increases generosity in humans. PLoS ONE 2007, 2:e1128.